Sai Life Sciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	911.19	236.57	699.12	1,159	667.52
Short-Term Investments	-	2,811	1,610	1,350	1,000	1,250
Cash & Short-Term Investments	4,639	3,723	1,847	2,049	2,159	1,918
Cash Growth	-	101.59%	-9.88%	-5.11%	12.61%	-
Accounts Receivable	-	7,544	5,624	4,618	4,893	4,221
Other Receivables	-	324.01	276.76	352.2	45.07	119.07
Receivables	-	7,868	5,901	4,971	4,938	4,342
Inventory	-	1,189	874.43	1,395	1,269	763.46
Prepaid Expenses	-	248.17	212.11	150.76	173.28	71.95
Restricted Cash	-	1,118	-	-	-	-
Other Current Assets	-	899.74	617.5	1,074	913.58	941.44
Total Current Assets	-	15,045	9,451	9,640	9,454	8,036
Property, Plant & Equipment	-	16,018	12,730	11,765	11,527	9,418
Long-Term Investments	-	19.43	18.68	18.68	0.16	5.16
Other Intangible Assets	-	108.56	137.73	114.33	80.5	55.75
Long-Term Deferred Tax Assets	-	141.97	131.33	80.62	57.06	-
Other Long-Term Assets	-	266.56	282.85	248.46	523.95	658.67
Total Assets	-	31,600	22,751	21,866	21,642	18,174
Accounts Payable	-	3,225	1,385	2,089	1,992	1,380
Accrued Expenses	-	1,208	869.78	203.54	146.72	162.77
Short-Term Debt	-	1,286	3,743	3,720	4,041	3,580
Current Portion of Long-Term Debt	-	-	586.13	662.95	500.88	322.96
Current Portion of Leases	-	590.58	417.76	373.49	245.61	106.4
Current Income Taxes Payable	-	79.7	-	33.67	25.67	3.01
Other Current Liabilities	-	935.19	397.62	505.76	194.45	433.05
Total Current Liabilities	-	7,325	7,399	7,589	7,146	5,988
Long-Term Debt	-	-	2,777	2,614	2,977	2,469
Long-Term Leases	-	1,647	1,757	1,958	1,896	269.6
Long-Term Deferred Tax Liabilities	-	1,110	862.66	625.34	625.99	613.77
Other Long-Term Liabilities	-	63.51	60.93	76.11	72.91	67.94
Total Liabilities	-	10,316	13,000	12,986	12,857	9,545
Common Stock	-	208.41	176.63	176.23	175.56	174.3
Additional Paid-In Capital	-	13,732	3,892	3,876	3,856	3,826
Retained Earnings	-	7,245	5,534	4,696	4,641	4,561
Comprehensive Income & Other	-	97.99	145.18	129.41	109.81	64.85
Total Common Equity	21,284	21,284	9,748	8,877	8,782	8,626
Shareholders' Equity	21,284	21,284	9,751	8,881	8,786	8,630
Total Liabilities & Equity	-	31,600	22,751	21,866	21,642	18,174
Total Debt	3,524	3,524	9,281	9,329	9,659	6,748
Net Cash (Debt)	1,115	198.71	-7,435	-7,279	-7,500	-4,830
Net Cash Per Share	5.43	1.01	-40.65	-39.91	-41.30	-28.02
Filing Date Shares Outstanding	208.55	208.41	183.92	176.23	175.56	169.4
Total Common Shares Outstanding	208.55	208.41	176.63	176.23	175.56	169.4
Working Capital	-	7,720	2,052	2,051	2,308	2,049
Book Value Per Share	102.24	102.12	55.19	50.37	50.02	50.92
Tangible Book Value	21,175	21,175	9,610	8,763	8,701	8,570
Tangible Book Value Per Share	101.71	101.60	54.41	49.72	49.56	50.59
Land	-	551.65	188.63	174.98	164.86	166.32
Buildings	-	3,552	3,055	2,614	2,134	1,786
Machinery	-	11,385	8,872	7,118	6,724	6,419
Construction In Progress	-	1,245	1,069	1,510	1,887	1,940
Leasehold Improvements	-	172.2	169.27	174.29	168.75	88.9

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.